Bioretec Oy (BRETEC.HE) Stock Price
Bioretec Oy Price
Revenue has compounded at 12.1% per year over the past 7 years to 3.52 M EUR. Bioretec Oy's net margin stands at -269.3%, up from -300.4% several years earlier.
Bioretec Oy stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Bioretec Oy business model & stock analysis
Frequently asked questions about Bioretec Oy
6 analysts currently rate the Bioretec Oy stock: 0 recommend buying, 2 holding and 4 selling. For 2026, analysts expect Bioretec Oy to generate revenue of 5.10 M EUR and earnings per share of -0.00 EUR.
The expected revenue of Bioretec Oy is 5.10 M EUR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Bioretec Oy is -307,900.00 EUR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Bioretec Oy is currently -22.85. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Bioretec Oy stock.
The price-to-sales ratio (P/S) of Bioretec Oy is currently 1.38. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Bioretec Oy stock.
The Eulerpool Quality Score for Bioretec Oy is 5/10.
The ISIN of Bioretec Oy is FI4000480454. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Bioretec Oy is A3C4QB. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Bioretec Oy is BRETEC.HE. The ticker symbol is used to trade Bioretec Oy shares on the stock exchange.
Bioretec Oy stock
Bioretec Oy Peer Group
Bioretec Oy FIGI
All fundamentals and in-depth analysis of Bioretec Oy
Our stock analysis for Bioretec Oy stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bioretec Oy. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.